rhodamine b has been researched along with dithiothreitol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, P; Liu, R; Wu, T; Zhao, X | 1 |
| Chen, YX; Fang, CJ; Feng, W; Guo, R; Li, LL; Lu, M; Ma, X; Peng, SQ; Wang, XZ; Yan, CH; Zhang, TL; Zhao, WH | 1 |
| Bong, KW; Choi, DG; Kim, HU; Lee, H; Shim, MS | 1 |
3 other study(ies) available for rhodamine b and dithiothreitol
| Article | Year |
|---|---|
Tunable redox-responsive hybrid nanogated ensembles.
Topics: Acrylic Resins; Cystamine; Disulfides; Dithiothreitol; Nanostructures; Oxidation-Reduction; Rhodamines; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Succinimides; X-Ray Diffraction | 2008 |
The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
Topics: Antineoplastic Agents; Apoptosis; Dithiothreitol; Doxorubicin; Drug Carriers; Folic Acid; Glutathione; HeLa Cells; Humans; Nanoparticles; Porosity; Rhodamines; Silicon Dioxide | 2012 |
Fabrication of dual stimuli-responsive multicompartmental drug carriers for tumor-selective drug release.
Topics: Antineoplastic Agents; Dithiothreitol; Drug Carriers; Drug Liberation; HeLa Cells; Humans; Hydrogen-Ion Concentration; Microfluidic Analytical Techniques; Neoplasms; Oxidation-Reduction; Rhodamines; Tumor Cells, Cultured | 2018 |